title: Recombinant-growth hormone (rec-hGH) therapy in infertile men with idiopathic oligozoospermia.
abstract: The study was designed to be an open test for short-term efficacy of rec hGH-therapy on spermatogenesis of ten infertile men with idiopathic severe oligozoospermia (1-5 x 10(6)) and normogonadotropinemia or moderate ipergonadotropinemia (FSH: range 1.90-9.60 IU/L, mean +/- SD 5.78 +/- 2.84; LH: 2.70-12.70 IU/L, mean +/- SD 6.60 +/- 3.61). FSH, LH, Testosterone, GH, and IGF-I were evaluated. Seminal parameters: sperm concentration, sperm motility and morphology were studied before and after therapy. Five responder patients showed an increase of seminal parameters both in sperm concentration and total number of motile spermatozoa. The short-term rec-hGH therapy significantly increased sperm concentration and total motile spermatozoa in five out of ten infertile patients who didn't show any modification in seminal parameters to other preavious treatment.
authors.affiliation: Laboratory of Seminology and Immunology of Reproduction, Institute of 5th Medical Clinic, University La Sapienza, Rome, Italy.
authors.forename: A
authors.initials: A
authors.lastname: Radicioni
authors.forename: E
authors.initials: E
authors.lastname: Paris
authors.forename: F
authors.initials: F
authors.lastname: Dondero
authors.forename: V
authors.initials: V
authors.lastname: Bonifacio
authors.forename: A
authors.initials: A
authors.lastname: Isidori
mesh_terms: D000328:Adult; D000728:Androgens / Q000097:blood; D001706:Biopsy; D004305:Dose-Response Relationship, Drug; D005640:Follicle Stimulating Hormone / Q000097:blood; D013006:Growth Hormone / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007248:Infertility, Male / Q000097:blood / Q000188:drug therapy*; D007279:Injections, Subcutaneous; D007334:Insulin-Like Growth Factor I / Q000032:analysis; D007986:Luteinizing Hormone / Q000097:blood; D008297:Male; D009845:Oligospermia / Q000097:blood / Q000188:drug therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use; D013076:Sperm Count / Q000187:drug effects; D013081:Sperm Motility / Q000187:drug effects; D013091:Spermatogenesis / Q000187:drug effects / Q000502:physiology; D013737:Testis / Q000502:physiology; D013739:Testosterone / Q000097:blood
chemical_list: D000728:Androgens; D011994:Recombinant Proteins; D013739:Testosterone; D007334:Insulin-Like Growth Factor I; D007986:Luteinizing Hormone; D005640:Follicle Stimulating Hormone; D013006:Growth Hormone